How much does each box of Opicapone cost? Introduction to price differences between different versions

Opicapone (Opicapone) is an auxiliary drug used to treat Parkinson's disease and belongs to the COMT inhibitor class of drugs. This drug mainly inhibits the metabolism of levodopa in the body and prolongs its efficacy, thereby reducing the occurrence of the "on-off" phenomenon in patients. At present, Opicapone has not been officially launched in my country, so if patients need to use it, they can only rely on overseas channels to purchase it.

In overseas markets, Opicapone is mainly developed and produced by the Portuguese pharmaceutical companyBIAL, and many European countries have approved its marketing. Since there is no legal generic version yet, all Opicapone currently on the market is the original drug. The common specifications are 50mg*30 tablets per box. The European original drug is priced at about more than 2,000 yuan. The price may fluctuate slightly in some countries and regions, but the overall price range is relatively stable.

Since there are no formal sales channels in China, if patients want to purchase Opicapone, they usually need to obtain it through qualified overseas medical institutions, international pharmacies or purchasing platforms. When choosing channels, special attention should be paid to the formality and safety of drugs. It is recommended to give priority to platforms with stable supply and clear sources of drugs to ensure drug quality and effectiveness.

In general, there is currently only the original version of Opicapone, the price is not low, and the access methods are relatively limited. For patients with Parkinson's disease who need to take long-term medication, the cost pressure is high. In the future, if the drug is approved for marketing in China, or legal and compliant generic drugs emerge, it will help reduce the economic burden on patients and expand its clinical accessibility. Until then, patients should consult a professional physician to evaluate their suitability before considering the use of Opicapone.

Reference materials:https://www.ongentys.com/